Suven Life Sciences has an EPS of $-6.63. In 2022, the company made an earnings per share (EPS) of $-9.05. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
Year | EPS | Change |
---|---|---|
2023 | -$6.63 | -26.74% |
2022 | -$9.05 | 73.21% |
2021 | -$5.22 | -23.38% |
2020 | -$6.82 | - |